|
Thomas M. Habermann MD, is a Professor of Medicine at Mayo Clinic College of Medicine and Associate Dean with a Mayo School of Graduate Medical Education.
He earned his medical degree at Creighton University and then completed internal medicine training at Mayo Clinic. He completed a hematology fellowship at Mayo Clinic and subsequently joined the faculty in 1985.
He has been the Chair of the Lymphoma Group at Mayo Clinic, since 1991. This group now includes 10 hematologists, 7 pathologists, and 27 other individuals. He has been the president of the North Star Foundation, since 2001, which is an organization involved in different issues, the most important of which include the initiative to have third-party carriers cover the routine costs of clinical trials.
He has been an active member of the Eastern Cooperative Oncology Group. He is the principal investigator of the ECOG Mayo U-10 Grant, Chair of the Fiscal Oversight Committee, member of the Foundation Committee, member of the Audit Committee, member of the Board of Advisors Committee, and member of the Executive Review Committee. His research grants include the Eastern Cooperative Oncology Group Grant, the Eastern Cooperative Oncology Group Outreach Program Grant, funding from the North Central Cancer Treatment Group as a scientific coordinator of the Audit Committee, Co-investigator of the Immunogenetic Determinance of?s??Non-Hodgkin's Lymphoma Survival, and a co-investigator on a Lymphoma Spore Grant.
Dr. Habermann is an author of numerous publications. He has served on the Editorial Board of the Journal of Clinical Oncology. He chaired the most recent national large cell lymphoma trial.
|
